172 related articles for article (PubMed ID: 35146135)
1. Distinct roles in phagocytosis of the early and late increases of cell surface calreticulin induced by oxaliplatin.
Matsusaka K; Azuma Y; Kaga Y; Uchida S; Takebayashi Y; Tsuyama T; Tada S
Biochem Biophys Rep; 2022 Mar; 29():101222. PubMed ID: 35146135
[TBL] [Abstract][Full Text] [Related]
2. Biphasic Increases of Cell Surface Calreticulin Following Treatment with Mitoxantrone.
Azuma Y; Suzuki K; Higai K; Matsumoto K; Tada S
Biol Pharm Bull; 2020 Oct; 43(10):1595-1599. PubMed ID: 32727970
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of photon, proton and carbon-ion radiation on the ecto-calreticulin exposure in various tumor cell lines.
Huang Y; Dong Y; Zhao J; Zhang L; Kong L; Lu JJ
Ann Transl Med; 2019 Oct; 7(20):542. PubMed ID: 31807524
[TBL] [Abstract][Full Text] [Related]
4. Late-stage inhibition of autophagy enhances calreticulin surface exposure.
Li DD; Xie B; Wu XJ; Li JJ; Ding Y; Wen XZ; Zhang X; Zhu SG; Liu W; Zhang XS; Peng RQ
Oncotarget; 2016 Dec; 7(49):80842-80854. PubMed ID: 27825129
[TBL] [Abstract][Full Text] [Related]
5. Endoplasmic reticulum calcium depletion impacts chaperone secretion, innate immunity, and phagocytic uptake of cells.
Peters LR; Raghavan M
J Immunol; 2011 Jul; 187(2):919-31. PubMed ID: 21670312
[TBL] [Abstract][Full Text] [Related]
6. Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal.
Garg AD; Elsen S; Krysko DV; Vandenabeele P; de Witte P; Agostinis P
Oncotarget; 2015 Sep; 6(29):26841-60. PubMed ID: 26314964
[TBL] [Abstract][Full Text] [Related]
7. Engineering Calreticulin-Targeting Monobodies to Detect Immunogenic Cell Death in Cancer Chemotherapy.
Zhang Y; Thangam R; You SH; Sultonova RD; Venu A; Min JJ; Hong Y
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199835
[TBL] [Abstract][Full Text] [Related]
8. Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia.
Wemeau M; Kepp O; Tesnière A; Panaretakis T; Flament C; De Botton S; Zitvogel L; Kroemer G; Chaput N
Cell Death Dis; 2010 Dec; 1(12):e104. PubMed ID: 21368877
[TBL] [Abstract][Full Text] [Related]
9. Ecto-calreticulin in immunogenic chemotherapy.
Obeid M; Tesniere A; Panaretakis T; Tufi R; Joza N; van Endert P; Ghiringhelli F; Apetoh L; Chaput N; Flament C; Ullrich E; de Botton S; Zitvogel L; Kroemer G
Immunol Rev; 2007 Dec; 220():22-34. PubMed ID: 17979837
[TBL] [Abstract][Full Text] [Related]
10. The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells.
Sen Santara S; Lee DJ; Crespo Â; Hu JJ; Walker C; Ma X; Zhang Y; Chowdhury S; Meza-Sosa KF; Lewandrowski M; Zhang H; Rowe M; McClelland A; Wu H; Junqueira C; Lieberman J
Nature; 2023 Apr; 616(7956):348-356. PubMed ID: 37020026
[TBL] [Abstract][Full Text] [Related]
11. Relative contribution of c1q and apoptotic cell-surface calreticulin to macrophage phagocytosis.
Verneret M; Tacnet-Delorme P; Osman R; Awad R; Grichine A; Kleman JP; Frachet P
J Innate Immun; 2014; 6(4):426-34. PubMed ID: 24557008
[TBL] [Abstract][Full Text] [Related]
12. Quantitative image analysis of intracellular protein translocation in 3-dimensional tissues for pharmacodynamic studies of immunogenic cell death.
Sun Y; Lu Z; Taylor JA; Au JLS
J Control Release; 2024 Jan; 365():89-100. PubMed ID: 37981052
[TBL] [Abstract][Full Text] [Related]
13. Calreticulin in phagocytosis and cancer: opposite roles in immune response outcomes.
Schcolnik-Cabrera A; Oldak B; Juárez M; Cruz-Rivera M; Flisser A; Mendlovic F
Apoptosis; 2019 Apr; 24(3-4):245-255. PubMed ID: 30929105
[TBL] [Abstract][Full Text] [Related]
14. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death.
Garg AD; Krysko DV; Verfaillie T; Kaczmarek A; Ferreira GB; Marysael T; Rubio N; Firczuk M; Mathieu C; Roebroek AJ; Annaert W; Golab J; de Witte P; Vandenabeele P; Agostinis P
EMBO J; 2012 Mar; 31(5):1062-79. PubMed ID: 22252128
[TBL] [Abstract][Full Text] [Related]
15. Endoplasmic reticulum stress-induced release and binding of calreticulin from human ovarian cancer cells.
Abdullah TM; Whatmore J; Bremer E; Slibinskas R; Michalak M; Eggleton P
Cancer Immunol Immunother; 2022 Jul; 71(7):1655-1669. PubMed ID: 34800147
[TBL] [Abstract][Full Text] [Related]
16. Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway.
Zitvogel L; Kepp O; Senovilla L; Menger L; Chaput N; Kroemer G
Clin Cancer Res; 2010 Jun; 16(12):3100-4. PubMed ID: 20421432
[TBL] [Abstract][Full Text] [Related]
17. Surface-exposed calreticulin in the interaction between dying cells and phagocytes.
Martins I; Kepp O; Galluzzi L; Senovilla L; Schlemmer F; Adjemian S; Menger L; Michaud M; Zitvogel L; Kroemer G
Ann N Y Acad Sci; 2010 Oct; 1209():77-82. PubMed ID: 20958319
[TBL] [Abstract][Full Text] [Related]
18. Primary phagocytosis of viable neurons by microglia activated with LPS or Aβ is dependent on calreticulin/LRP phagocytic signalling.
Fricker M; Oliva-Martín MJ; Brown GC
J Neuroinflammation; 2012 Aug; 9():196. PubMed ID: 22889139
[TBL] [Abstract][Full Text] [Related]
19. Emerging Roles of Calreticulin in Cancer: Implications for Therapy.
Venkateswaran K; Verma A; Bhatt AN; Shrivastava A; Manda K; Raj HG; Prasad A; Len C; Parmar VS; Dwarakanath BS
Curr Protein Pept Sci; 2018 Feb; 19(4):344-357. PubMed ID: 28079009
[TBL] [Abstract][Full Text] [Related]
20. Imaging Calreticulin for Early Detection of Immunogenic Cell Death During Anticancer Treatment.
Kim DY; Pyo A; Yun M; Thangam R; You SH; Zhang Y; Jung YR; Nguyen DH; Venu A; Kim HS; Yoon MS; Hong Y; Min JJ
J Nucl Med; 2021 Jul; 62(7):956-960. PubMed ID: 33509975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
